FDA reviews Avandia safety data

Tuesday, February 23, 2010 - 09:07 in Health & Medicine

WASHINGTON, Feb. 23 (UPI) -- The U.S. Food and Drug Administration says it is reviewing data from a long-term study concerning possible cardiovascular risks with the drug Avandia.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net